They scooped up 334,227 shares, according to the SEC filing. Which, when you break it down, is a lot of shares. My aunt Mildred buys shares, too, but it’s usually in companies that make porcelain dolls. Different strategies, I suppose. Elevation Capital is clearly betting on “fallen angels” – companies that were once considered safe investments, then…weren’t. It’s a lovely phrase, really. Fallen angels. Sounds like a particularly gloomy rock band.
The feverish pursuit of this intelligence, this phantom born of silicon and code, has driven valuations to heights that make even the most seasoned investor pause, a collective breath held against the inevitable correction. Yet, to shy away entirely is to misunderstand the nature of these cycles, to believe that progress can be neatly contained within a spreadsheet. The true opportunity, as always, lies not in chasing the ephemeral peak, but in identifying the quiet foundations upon which it rests.
The market, ever prone to fits of delayed recognition, has yet to fully account for this shift. Consequently, certain equities present themselves as opportunities – not for reckless speculation, but for the patient investor, one who understands that true value often resides in the overlooked or momentarily unfashionable. There are, too, those that bear the marks of a recent, perhaps overdone, correction, offering a chance to acquire sound businesses at a reasonable price.
The catalyst? A revised price target from Cantor Fitzgerald’s Derek Soderberg, a bold $35, issued in the wake of the recent sell-off. One wonders, however, if this is a reasoned assessment, or merely a desperate attempt to impose order upon a fundamentally chaotic situation. The markets abhor a vacuum, and perhaps this price target is simply the nearest solid object upon which to anchor a failing narrative.
The fourth-quarter results, announced with the usual fanfare, were, predictably, disappointing. A mere 4% decline in revenue, they assure us, and earnings marginally improved. A triumph, no doubt, if one discounts the subsequent guidance, which sent the shares tumbling with the swiftness of a disgraced diplomat. Break-even earnings are projected for the current quarter, a stark contrast to the expectations of a modest profit. The market, it seems, prefers its illusions undisturbed.
The challenge, naturally, isn’t finding ETFs. It’s finding the right ones. There are more ETFs than there are varieties of tea (and that’s saying something, considering the British Empire was built on the stuff). So, let’s consider a couple that, while not guaranteeing immortality or a free trip to Alpha Centauri, might just provide a reasonable return on investment over the long term. We’ll look at the Invesco QQQ Fund (QQQ 0.36%) and the Vanguard Growth Index Fund (VUG 0.48%). Because, frankly, staring into the abyss of endless investment options is exhausting, even for a seasoned observer of market absurdities.
This leveraged charade collapsed as XRP tumbled below its key support, like a debutante tripping on her own hem. The price plummeted from $1.81 to $1.71, leaving over-leveraged longs in a state of financial disarray. One can almost hear the wails of the bulls as their positions were swept away in a torrent of poor judgment.
In this grand farce of a sell-off, SOL has emerged as the hapless protagonist, losing its grip on the $118 support level-a bastion it had defended with the fervor of a knight guarding a dragon’s lair since March 2024. Alas, even dragons must eventually nap, and so the fortress fell.
Vernova deals not in gewgaws and trinkets, but in the colossal architecture of power generation. Forget the humble light switch; imagine instead the leviathan grace of gas turbines, the wind-harvesting sentinels of the open field. These are not impulse buys; they are decades-long commitments, favored by utilities whose horizons stretch further than most investment strategies. And, crucially, Vernova operates within sectors often characterized by oligopolistic calm – a comforting predictability for those who prefer a limited field of competitors. They aren’t merely in the game, they’ve subtly reshaped its rules.
The numbers themselves were…fine. $81.3 billion in revenue? Beating expectations by a cool $1.1 billion? $4.14 EPS, twenty-two cents above the consensus? Sounds like a win, right? WRONG. It’s the hidden numbers that always get you. The ones buried beneath the press releases and carefully crafted narratives. This wasn’t a failure of performance; it was a failure of perception. Investors aren’t rewarding growth anymore; they’re demanding immediate gratification. They want to see a return on the AI arms race, and they want it NOW. And Microsoft is currently burning cash like a rock star with a trust fund and a penchant for self-destruction.